Biofermin Pharmaceutical. (4517.TSE) Q3 2019 Earnings

30OctExpected
Q4 2018
Q1 2019
Q2 2019
Q3 2019
31.79
39.62
47.45
55.28

Details

Expected EPS
N/A
Actual EPS
55.2808
Surprise EPS
55.28
Surprise Percent
+∞%

Description

Biofermin Pharmaceutical. (4517.TSE) has reported earnings of 55.2808 per share for Q3 2019.

0 Comments

Share your thoughts